Total Payments
$13,937
2024 Payments
$313.99
Companies
20
Transactions
120
Medicare Patients
1,620
Medicare Billing
$247,196
Payment Breakdown by Category
Education$6,000 (43.1%)
Travel$5,202 (37.3%)
Food & Beverage$2,735 (19.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $6,000 | 2 | 43.1% |
| Travel and Lodging | $5,202 | 12 | 37.3% |
| Food and Beverage | $2,735 | 106 | 19.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $8,510 | 14 | $0 (2022) |
| BOSTON SCIENTIFIC CORPORATION | $1,735 | 7 | $0 (2017) |
| Veran Medical Technologies, Inc. | $1,598 | 4 | $0 (2019) |
| GlaxoSmithKline, LLC. | $763.25 | 43 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $721.07 | 25 | $0 (2024) |
| PFIZER INC. | $127.65 | 2 | $0 (2020) |
| Insmed, Inc. | $84.94 | 3 | $0 (2024) |
| GENZYME CORPORATION | $71.24 | 3 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $47.36 | 6 | $0 (2017) |
| United Therapeutics Corporation | $37.24 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $313.99 | 18 | GlaxoSmithKline, LLC. ($135.00) |
| 2023 | $158.11 | 8 | GlaxoSmithKline, LLC. ($107.77) |
| 2022 | $8,597 | 19 | Intuitive Surgical, Inc. ($8,435) |
| 2021 | $289.37 | 14 | AstraZeneca Pharmaceuticals LP ($76.60) |
| 2020 | $459.51 | 10 | AstraZeneca Pharmaceuticals LP ($288.70) |
| 2019 | $1,552 | 12 | Veran Medical Technologies, Inc. ($1,250) |
| 2018 | $123.75 | 11 | GlaxoSmithKline, LLC. ($106.09) |
| 2017 | $2,443 | 28 | BOSTON SCIENTIFIC CORPORATION ($1,735) |
All Payment Transactions
120 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.32 | General |
| Category: Cardiovascular | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.12 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.30 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Immunology | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: IMMUNOLOGY | ||||||
| 07/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: RESPIRATORY | ||||||
| 06/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Respiratory | ||||||
| 02/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: RESPIRATORY | ||||||
| 02/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: IMMUNOLOGY | ||||||
| 02/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.25 | General |
| Category: IMMUNOLOGY | ||||||
| 01/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.96 | General |
| Category: IMMUNOLOGY | ||||||
| 01/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: IMMUNOLOGY | ||||||
| 04/05/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Respiratory | ||||||
| 04/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: RESPIRATORY | ||||||
| 02/22/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Respiratory | ||||||
| 02/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 641 | 741 | $468,922 | $73,878 |
| 2022 | 8 | 449 | 563 | $273,637 | $60,845 |
| 2021 | 7 | 290 | 393 | $208,415 | $57,205 |
| 2020 | 7 | 240 | 383 | $283,224 | $55,268 |
Total Patients
1,620
Total Services
2,080
Medicare Billing
$247,196
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 149 | 149 | $113,468 | $27,137 | 23.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 109 | 154 | $85,138 | $22,140 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 130 | 169 | $59,458 | $15,659 | 26.3% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 28 | 29 | $191,400 | $6,663 | 3.5% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 71 | 76 | $4,560 | $874.48 | 19.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 73 | 78 | $7,254 | $664.30 | 9.2% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 50 | 54 | $3,996 | $442.68 | 11.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 31 | 32 | $3,648 | $296.46 | 8.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 104 | 174 | $53,492 | $18,020 | 33.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 91 | 91 | $56,565 | $17,706 | 31.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 43 | 61 | $28,721 | $9,035 | 31.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 41 | $20,295 | $6,950 | 34.2% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2022 | 17 | 17 | $90,750 | $3,940 | 4.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $11,040 | $3,603 | 32.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 51 | 52 | $2,964 | $606.46 | 20.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 53 | 54 | $4,806 | $477.32 | 9.9% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 30 | 31 | $2,170 | $254.94 | 11.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 26 | 26 | $2,834 | $253.38 | 8.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 70 | 70 | $39,178 | $15,173 | 38.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 32 | 79 | $39,105 | $14,198 | 36.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 49 | 86 | $25,167 | $9,687 | 38.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 42 | 58 | $24,887 | $9,501 | 38.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 22 | 22 | $15,180 | $4,967 | 32.7% |
| 31652 | Examination of lung airways using an endoscope with imaging guidance and ultrasound, 1 or 2 lymph nodes involved | Facility | 2021 | 11 | 12 | $59,400 | $2,969 | 5.0% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 22 | 23 | $1,311 | $288.96 | 22.0% |
About Dr. Marek Martynowicz, MD
Dr. Marek Martynowicz, MD is a Pulmonary Disease healthcare provider based in Anchorage, Alaska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962581249.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marek Martynowicz, MD has received a total of $13,937 in payments from pharmaceutical and medical device companies, with $313.99 received in 2024. These payments were reported across 120 transactions from 20 companies. The most common payment nature is "Education" ($6,000).
As a Medicare-enrolled provider, Martynowicz has provided services to 1,620 Medicare beneficiaries, totaling 2,080 services with total Medicare billing of $247,196. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Anchorage, AK
- Active Since 11/06/2006
- Last Updated 01/06/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1962581249
Products in Payments
- ION (Device) $6,000
- Da Vinci Surgical System (Device) $2,510
- GENERAL - PULMONARY (Device) $1,640
- Spin (Device) $1,598
- TRELEGY ELLIPTA (Drug) $286.46
- NUCALA (Biological) $234.62
- TAGRISSO (Drug) $125.00
- BREZTRI AEROSPHERE (Drug) $116.98
- BREZTRI (Drug) $115.32
- ELIQUIS (Drug) $110.46
- BREO (Drug) $105.86
- BEVESPI AEROSPHERE (Drug) $103.77
- DUPIXENT (Biological) $102.92
- INCRUSE (Drug) $98.13
- Arikayce (Drug) $84.94
- ALAIR BRONCHIAL THERMOPLASTY SYSTEM (Device) $67.42
- TEZSPIRE (Biological) $60.72
- AIRSUPRA (Drug) $54.43
- FASENRA (Biological) $52.64
- SYMBICORT (Drug) $45.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Anchorage
John Clark, Md, MD
Pulmonary Disease — Payments: $1,122
Pulmonary Disease $1,122
Beth Baker, Md, MD
Pulmonary Disease — Payments: $796.55
Pulmonary Disease $796.55
Gregory Gerboth, Md, MD
Pulmonary Disease — Payments: $754.41
Pulmonary Disease $754.41
Denise Wurth, Md, MD
Pulmonary Disease — Payments: $421.14
Pulmonary Disease $421.14
David Zielke, Md, MD
Pulmonary Disease — Payments: $120.58
Pulmonary Disease $120.58
Dr. David Frankl, M.d., M.p.h, M.D., M.P.H
Pulmonary Disease — Payments: $67.76
Pulmonary Disease $67.76